IceCure wins China NMPA approval to market ProSense cryoablation system
ICCM•China approval for ProSense
- IceCure Medical won China NMPA clearance to market its ProSense cryoablation system as a Class III medical device.
- The approval allows commercial sales in China under the registered indications for ProSense and its cryoprobes.
